WARNER-LAMBERT's QUINOLONE ENOXACIN NDA COVERS FIVE SEPARATE INDICATIONS, FIRM SAYS; R&D PROGRAM FEATURING CNS, CARDIOVASCULAR AND ANTICANCER PRODUCTS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".